- Home
- CBRE vs COO Comparison
CBRE vs COO Comparison
Compare CBRE & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBRE
- COO
- Stock Information
- Founded
- CBRE 1906
- COO 1980
- Country
- CBRE United States
- COO United States
- Employees
- CBRE N/A
- COO N/A
- Industry
- CBRE Real Estate
- COO Ophthalmic Goods
- Sector
- CBRE Finance
- COO Health Care
- Exchange
- CBRE Nasdaq
- COO Nasdaq
- Market Cap
- CBRE 41.3B
- COO 16.4B
- IPO Year
- CBRE 2004
- COO N/A
- Fundamental
- Price
- CBRE $139.33
- COO $70.90
- Analyst Decision
- CBRE Buy
- COO Strong Buy
- Analyst Count
- CBRE 9
- COO 9
- Target Price
- CBRE $150.33
- COO $99.67
- AVG Volume (30 Days)
- CBRE 1.4M
- COO 3.2M
- Earning Date
- CBRE 07-29-2025
- COO 05-29-2025
- Dividend Yield
- CBRE N/A
- COO N/A
- EPS Growth
- CBRE 2.39
- COO 21.77
- EPS
- CBRE 3.28
- COO 2.07
- Revenue
- CBRE $36,742,000,000.00
- COO $3,988,200,000.00
- Revenue This Year
- CBRE $14.60
- COO $6.79
- Revenue Next Year
- CBRE $9.27
- COO $6.44
- P/E Ratio
- CBRE $42.56
- COO $34.29
- Revenue Growth
- CBRE 13.15
- COO 6.88
- 52 Week Low
- CBRE $85.74
- COO $65.00
- 52 Week High
- CBRE $147.75
- COO $112.38
- Technical
- Relative Strength Index (RSI)
- CBRE 63.94
- COO 41.11
- Support Level
- CBRE $134.35
- COO $69.01
- Resistance Level
- CBRE $140.25
- COO $71.48
- Average True Range (ATR)
- CBRE 2.86
- COO 1.57
- MACD
- CBRE 0.50
- COO 0.32
- Stochastic Oscillator
- CBRE 85.21
- COO 36.79
About CBRE CBRE Group Inc
CBRE Group provides a wide range of real estate services to owners, occupants, and investors worldwide, including leasing, property and project management, and capital markets advisory. CBRE's investment management arm manages over $140 billion for clients across diverse public and private real estate strategies.
About COO The Cooper Companies Inc.
CooperCompanies is one of the largest eyecare companies in the us. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the us contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the us, and controls 17% of the us IUD market.